埃及引入了新的肝癌免疫治疗药物,加强了22个单位的治疗选择。 Egypt introduces new immunotherapy drugs for liver cancer, enhancing treatment options across 22 units.

埃及卫生部根据国际准则增加了一种新的免疫治疗药物Tremelimumab/Durvalumab,用于治疗肝癌病人。 Egypt's Ministry of Health has added a new immunotherapy drug, Tremelimumab/Durvalumab, to treat liver cancer patients, following international guidelines. 更新内容包括全国22个治疗单位提供的两种免疫治疗药物和口服动脉抑制剂。 The update includes two immunotherapy drugs and oral kinase inhibitors, available at 22 treatment units across the country. 该部还建立了58个早期肝肿瘤识别检测中心,并向119 000多名肝病患者提供服务。 The ministry has also set up 58 detection centers for early liver tumor identification and has provided services to over 119,000 liver disease patients.